Food, Drug, and Cosmetic Act ( 21 U.S.C. 355 ) or section 351 of the Public Health Service Act ( 42 U.S.C. 262 ) after the date of enactment of this Act, each manufacturer, not later than 45 days prior to introducing such prescription drug into interstate commerce in the United States, shall provide to the Bureau the following information: (A) The information described in the following provisions of paragraph (2)(A): (i) Clauses (i) through (vi). (ii) Subclauses (I) through (IV) of clause (vii). (iii) Clauses (xi) through (xiv). (B) Pricing information with respect to the sale of such prescription drug, including— (i) the planned introductory wholesale acquisition cost